肾移植中他克莫司通用制剂：谷血药浓度作为药物暴露的替代指标。 - Suppr

Suppr

超能文献

Generic tacrolimus in renal transplantation: trough blood concentration as a surrogate for drug exposure.

作者信息

Connor Andrew, Prowse Andrew, MacPhee Iain, Rowe Peter A

出版信息

Transplantation. 2012 Jun 27;93(12):e45-6. doi: 10.1097/TP.0b013e318256dd13.

DOI:10.1097/TP.0b013e318256dd13

PMID:23318306

Abstract

摘要

相似文献

Generic tacrolimus in renal transplantation: trough blood concentration as a surrogate for drug exposure.肾移植中他克莫司通用制剂：谷血药浓度作为药物暴露的替代指标。

Transplantation. 2012 Jun 27;93(12):e45-6. doi: 10.1097/TP.0b013e318256dd13.

De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring.肾移植中他克莫司通用制剂与参比他克莫司的初治使用：临床结果、方案活检组织学及免疫监测评估

Transpl Int. 2015 Nov;28(11):1283-90. doi: 10.1111/tri.12626. Epub 2015 Jul 14.

Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients.在儿科肾移植受者中进行全国范围内的他克莫司通用转换。

Pediatr Nephrol. 2017 Nov;32(11):2125-2131. doi: 10.1007/s00467-017-3707-3. Epub 2017 Jun 28.

Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.肾移植受者中通过抗体偶联磁免疫测定法测得的他克莫司血谷浓度假性异常升高：一例报告

Transplant Proc. 2012 Jan;44(1):134-6. doi: 10.1016/j.transproceed.2011.11.043.

Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure.肾移植受者从普乐可复转换为阿德福韦酯可导致他克莫司暴露持续减少。

Transplantation. 2011 Mar 15;91(5):566-9. doi: 10.1097/TP.0b013e3182098ff0.

Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.达他克莫司血药浓度峰值的时间、平均驻留时间与急性肾移植排斥反应：一项针对成年受者的开放标签、前瞻性药代动力学研究。

Clin Ther. 2004 Nov;26(11):1834-44. doi: 10.1016/j.clinthera.2004.11.004.

Association of the combination of time-weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation.他克莫司血药浓度时间加权变异度与低药物暴露联合对肾移植后移植物存活的影响。

Nephrol Dial Transplant. 2017 Feb 1;32(2):393-399. doi: 10.1093/ndt/gfw394.

Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.转换为每日一次给药方案的稳定肾移植患者的他克莫司谷浓度及浓度-剂量比

Transplant Proc. 2011 May;43(4):1024-7. doi: 10.1016/j.transproceed.2011.02.049.

Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.CYP3A5和MDR1基因多态性对肾移植术后早期他克莫司血药浓度的影响

Clin Transplant. 2005 Oct;19(5):638-43. doi: 10.1111/j.1399-0012.2005.00370.x.

[Blood concentrations and side effects of tacrolimus in a living renal transplantation].[他克莫司在活体肾移植中的血药浓度及副作用]

Masui. 2001 Mar;50(3):246-50.

引用本文的文献

A single-centre comparison of the clinical outcomes at 6 months of renal transplant recipients administered Adoport or Prograf preparations of tacrolimus.一项关于接受他克莫司Adoport制剂或Prograf制剂治疗的肾移植受者6个月临床结局的单中心比较。

Clin Kidney J. 2013 Feb;6(1):21-28. doi: 10.1093/ckj/sfs154. Epub 2012 Nov 21.

Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis.实体器官移植中的通用免疫抑制：系统评价和荟萃分析。

BMJ. 2015 Jun 22;350:h3163. doi: 10.1136/bmj.h3163.

Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution.病例报告：在一名儿科异基因干细胞移植患者中，通用名药物替换后无法达到他克莫司的治疗剂量。

BMC Pharmacol Toxicol. 2014 Dec 3;15:69. doi: 10.1186/2050-6511-15-69.

Systematic conversion to generic tacrolimus in stable kidney transplant recipients.稳定期肾移植受者系统性转换为使用他克莫司仿制药。

Clin Kidney J. 2014 Apr;7(2):151-155. doi: 10.1093/ckj/sfu015. Epub 2014 Mar 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验